117 “Arming” the Chimeric Oncolytic Adenovirus Enadenotucirev to Deliver Checkpoint Inhibitors and Other Therapeutics Directly to Tumours

European Journal of Cancer - United Kingdom
doi 10.1016/s0959-8049(14)70243-6
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV


Related search